Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Apr 14, 2022 12:05pm
149 Views
Post# 34604058

RE:RE:Survey Says

RE:RE:Survey Says

Sailboatdream wrote: Certainly not expecting a "magic bullet" deal.  So much to do in the next 3 years if they want to be revenue generating in 2026 as per analyst reports.  Access to cells, instrumentation, marketing to insurance cos and govts, sales, training, manufacturing... and list goes on.  And they haven't landed a single one of these deals in the past 15 months.  So basically anything to get the ball rolling.  Best case would be a full buyout which would resolve all issues at once... and would support the company with strong management.  


i totally agree with your assesssment sailboat. It's a year later since last AGM, and still no deal of any type.  So everything will be fine after the deal ? The lack of transparency , arrogance , inability to execute any type of business plan is not a good forecast for the future in my opinion . Maybe they get it done in the next few months , but what happens after ? Will management be able to move things along rapidly ? Vertex is moving along and has lots of publicity . We have Ray Matthews , new PR guy and nothing .....

How long before the money runs out ? Tsx listing failure is a signature incompetence of management . No update or excuses . Why announce it in the first place and have a deadline ? 

Europe meeting will be a non factor . Actually it will be sold or already has sold .

I wonder how happy Wally is ?


MS

 

<< Previous
Bullboard Posts
Next >>